Jazz Pharmaceuticals PLC (JAZZ): Market Valuation

Jazz Pharmaceuticals is optimizing costs by outsourcing drug manufacturing to third-party contractors while maintaining its leadership in epilepsy and sleep disorder therapies through patent protection. This price chart on GURU.Markets shows a market capitalization of 15.39. The business strategy relies on a robust scientific foundation in oncology and neurobiology aimed at discovering new treatments for rare pathologies.

JAZZ (Jazz Pharmaceuticals plc) Market Valuation history from 07/04/2022 to 11/13/2026

Comprehensive metric breakdowns and analytics for Jazz Pharmaceuticals Corp (JAZZ)

- current price and projected stock value:

Stock Price Jazz Pharmaceuticals plc|JAZZ - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Valuation Jazz Pharmaceuticals Corp|JAZZ - Full Business Value

- business book valuation details:

Accounting Value per Share Jazz Pharmaceuticals|JAZZ - Net Asset Value|Market Value to Book Value Ratio jazzpharma.com|JAZZ - Total Asset Value of Company

- debt burden and liquidity indicators:

Total Debt to Capital Jazz Pharmaceuticals|JAZZ - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Jazz Pharmaceuticals|JAZZ - Company Aggregate Debts|Debt to Book Capitalization Ratio Jazz Pharmaceuticals Corp|JAZZ - Company Long-Term Loans and Borrowings|Company Short-Term Debt Jazz Pharmaceuticals|Quick Ratio jazzpharma.com

- net income and valuation multiples indicators:

JAZZ - Net Profit|Future Profit Jazz Pharmaceuticals|JAZZ - Company Value to Net Income|Future Price to Earnings Jazz Pharma|JAZZ - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Jazz Pharmaceuticals Corp|JAZZ - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Jazz Pharmaceuticals|JAZZ - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months jazzpharma.com|JAZZ - Earnings per share increase in current year|Net earnings per share growth forecast for next year Jazz Pharmaceuticals

- sales volume and revenue information:

JAZZ - Company Total Revenue|Company Projected Revenue Jazz Pharmaceuticals plc|JAZZ - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Jazz Pharmaceuticals Corp

Fundamental company analysis:JAZZ (Jazz Pharmaceuticals plc)

Product sample of Jazz Pharmaceuticals Corp

Market capitalization determines the total value of all the issuer's shares, allowing for a comparison between the exchange valuation and the actual operational efficiency of the business. By analyzing the company's market value, an investor can assess the extent to which the market prices in the risks of replacing legacy drugs with new analogs and the approval timelines for oncology medications, given the current stable liquidity levels of Jazz Pharmaceuticals (JAZZ).

Key competitors